miR-29 targeted several extracellular matrix genes including COL1A2, COL3A1 and COL5A2, and has been validated in nasopharyngeal carcinomas and HTM (human trabecular meshwork) cells [63,64]. Here, COL1A2 is linked to nasopharyngeal carcinoma.